Search research articles
Contact Us
Filters
Showing results (171-180 of 177) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 177 results.
JAMA Oncology
|
July 17, 2015
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
Niki Karachaliou, Clara Mayo-de las Casas, Cristina Queralt, et al.
Nature Genetics
|
February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin, Amit J Sabnis, Elton Chan, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Imane Chaib, Niki Karachaliou, Sara Pilotto, et al.
The Lancet. Oncology
|
January 31, 2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 3, 2023
Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network
Ulises Garza-Ramos, Jesús Silva-Sánchez, Luis Esaú López-Jácome, et al.
Science (New York, N.Y.)
|
July 16, 2005
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease
Najib M El-Sayed, Peter J Myler, Daniella C Bartholomeu, et al.
Ecology
|
April 27, 2022
NEOTROPICAL FRESHWATER FISHES: A dataset of occurrence and abundance of freshwater fishes in the Neotropics
Lívia Helena Tonella, Renata Ruaro, Vanessa Salete Daga, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 177) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 177 results.
JAMA Oncology
|
July 17, 2015
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
Niki Karachaliou, Clara Mayo-de las Casas, Cristina Queralt, et al.
Nature Genetics
|
February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin, Amit J Sabnis, Elton Chan, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Imane Chaib, Niki Karachaliou, Sara Pilotto, et al.
The Lancet. Oncology
|
January 31, 2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
January 3, 2023
Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network
Ulises Garza-Ramos, Jesús Silva-Sánchez, Luis Esaú López-Jácome, et al.
Science (New York, N.Y.)
|
July 16, 2005
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease
Najib M El-Sayed, Peter J Myler, Daniella C Bartholomeu, et al.
Ecology
|
April 27, 2022
NEOTROPICAL FRESHWATER FISHES: A dataset of occurrence and abundance of freshwater fishes in the Neotropics
Lívia Helena Tonella, Renata Ruaro, Vanessa Salete Daga, et al.
Page
of 18